Azenta appoints interim CEO and grants retention RSUs
Azenta said Dr. Martin D. Madaus will become interim president and chief executive officer effective Aug. 22, 2026. The company also approved his compensation and equity grants and awarded retention restricted stock units to four executives.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.